By Davit Kirakosyan
Goldman Sachs upgraded Vir Biotechnology (NASDAQ: VIR ) to Buy from Neutral and raised its price target to $53.00 from $41.00, noting compelling risk/reward for an underappreciated catalyst with the potential to drive a major new leg of growth.
Goldman Sachs also said the company will report VIR-2482 data in mid-2023, and it expects to see "meaningfully better efficacy" than currently approved and rival pipeline-stage flu vaccines.
Shares surged more than 13% intra-day today.
Wolfe Research upgraded Norfolk Southern (NYSE: NSC ) to Outperform from Peerperform with a price target of $255.00.
Since the major Ohio derailment about two weeks ago, the company’s shares are down almost 10%, while the other U.S. rails are down 4%. However, according to Wolfe Research, near-term trends are looking more favorable for the company, with volumes up 3% quarter-to-date, the best among the U.S. rails.
At the same time, met coal prices have rebounded from H2 levels and are now at their highest level since last June.
Shares were trading around 2% lower intra-day today.
CFRA upgraded Molson Coors (NYSE: TAP ) to Hold from Sell and raised its price target to $50.00 from $45.00.
Shares gained more than 8% intra-day today after the company reported its Q4 results, with EPS of $1.30 coming in better than the consensus estimate of $1.07. Revenue was $2.63 billion, slightly missing the consensus estimate of $2.64B.
Raymond James upgraded Prosperity Bancshares (NYSE: PB ) to Outperform from Market Perform with a price target of $85.00.
Piper Sandler upgraded Caleres (NYSE: CAL ) to Overweight from Neutral and raised its price target to $35.00 from $26.00 following Wednesday’s pre-announcement underpinned by 2023 earnings reset coupled with further confidence in EPS gains being structural in nature.
Shares were up 6% intra-day today.
Guggenheim upgraded Alliant Energy (NASDAQ: LNT ) to Neutral from Sell.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.